FXa inhibition by rivaroxaban modifies mechanisms associated with the pathogenesis of human abdominal aortic aneurysms

  1. Moñux, G.
  2. Zamorano-León, J.J.
  3. Marqués, P.
  4. Sopeña, B.
  5. García-García, J.M.
  6. Laich de Koller, G.
  7. Calvo-Rico, B.
  8. García-Fernandez, M.A.
  9. Serrano, J.
  10. López-Farré, A.
Aldizkaria:
British Journal of Clinical Pharmacology

ISSN: 1365-2125,  0306-5251

Argitalpen urtea: 2017

Alea: 83

Zenbakia: 12

Orrialdeak: 2661-2670

Mota: Artikulua

DOI: 10.1111/BCP.13383 GOOGLE SCHOLAR lock_openSarbide irekia editor
Datuen iturria: Scopus